Cognition Therapeutics Inc. (CGTX)
Cognition Therapeutics Inc. (CGTX) Insider Trading
Directors, officers and holders of more than 10% of CGTX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 50 transactions on file: 4 with code P, 0 with code S and 46 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Fletcher Aaron G.L. | Director | A Award | 25,000 | Not measured | Not measured |
| Jun 17, 2026 | Khattar Jack A. | Director | A Award | 25,000 | Not measured | Not measured |
| Jun 17, 2026 | Monia Brett P | Director | A Award | 25,000 | Not measured | Not measured |
| Jun 17, 2026 | Wallace Peggy | Director | A Award | 25,000 | Not measured | Not measured |
| Jun 17, 2026 | RICHSTONE ELLEN B | Director | A Award | 25,000 | Not measured | Not measured |
| May 1, 2026 | Doyle John Brendan | Chief Financial Officer | F Tax Payment | 8,567 | $1.28 | $10,966 |
| Apr 16, 2026 | Caggiano Anthony | Chief Medical Officer | P Purchase | 10,000 | $1.11 | $11,100 |
| Apr 16, 2026 | Doyle John Brendan | Chief Financial Officer | P Purchase | 10,000 | $1.13 | $11,300 |
| Apr 16, 2026 | Ricciardi Lisa | CEO & President | P Purchase | 9,175 | $1.10 | $10,093 |
| Feb 15, 2026 | Doyle John Brendan | Chief Financial Officer | F Tax Payment | 1,560 | $1.12 | $1,747 |
| Feb 15, 2026 | Ricciardi Lisa | CEO & President | F Tax Payment | 5,850 | $1.12 | $6,552 |
| Feb 15, 2026 | Caggiano Anthony | Chief Medical Officer | F Tax Payment | 4,680 | $1.12 | $5,242 |
| Feb 4, 2026 | Doyle John Brendan | Chief Financial Officer | F Tax Payment | 26,921 | $1.03 | $27,729 |
| Feb 4, 2026 | Ricciardi Lisa | CEO & President | F Tax Payment | 51,704 | $1.03 | $53,255 |
| Feb 4, 2026 | Caggiano Anthony | Chief Medical Officer | F Tax Payment | 26,919 | $1.03 | $27,727 |
| Feb 3, 2026 | Ricciardi Lisa | CEO & President | F Tax Payment | 26,036 | $1.12 | $29,160 |
| Feb 3, 2026 | Ricciardi Lisa | CEO & President | A Award | 800,000 | Not measured | Not measured |
| Feb 3, 2026 | Caggiano Anthony | Chief Medical Officer | F Tax Payment | 11,488 | $1.12 | $12,867 |
| Feb 3, 2026 | Caggiano Anthony | Chief Medical Officer | A Award | 400,000 | Not measured | Not measured |
| Feb 3, 2026 | Doyle John Brendan | Chief Financial Officer | A Award | 200,000 | Not measured | Not measured |
| Dec 18, 2025 | Ricciardi Lisa | CEO & President | A Award | 75,000 | Not measured | Not measured |
| Dec 18, 2025 | Caggiano Anthony | Chief Medical Officer | A Award | 65,000 | Not measured | Not measured |
| Dec 18, 2025 | Caggiano Anthony | Chief Medical Officer | F Tax Payment | 20,280 | $1.50 | $30,420 |
| Dec 18, 2025 | Doyle John Brendan | Chief Financial Officer | A Award | 30,000 | Not measured | Not measured |
| Dec 18, 2025 | Doyle John Brendan | Chief Financial Officer | F Tax Payment | 9,360 | $1.50 | $14,040 |
| Dec 18, 2025 | Ricciardi Lisa | CEO & President | F Tax Payment | 23,400 | $1.50 | $35,100 |
| Sep 19, 2025 | Fletcher Aaron G.L. | Director | M Exercise | 7,729 | Not measured | Not measured |
| Sep 19, 2025 | Fletcher Aaron G.L. | Director | M Exercise | 7,729 | $0.8400 | $6,492 |
| Jul 29, 2025 | Ricciardi Lisa | CEO & President | A Award | 75,000 | Not measured | Not measured |
| Jul 29, 2025 | Ricciardi Lisa | CEO & President | F Tax Payment | 23,400 | $0.6702 | $15,683 |
| Jul 29, 2025 | Doyle John Brendan | Chief Financial Officer | F Tax Payment | 9,360 | $0.6702 | $6,273 |
| Jul 29, 2025 | Doyle John Brendan | Chief Financial Officer | A Award | 30,000 | Not measured | Not measured |
| Jul 29, 2025 | Caggiano Anthony | Chief Medical Officer | F Tax Payment | 20,281 | $0.6702 | $13,592 |
| Jul 29, 2025 | Caggiano Anthony | Chief Medical Officer | A Award | 65,000 | Not measured | Not measured |
| Jun 18, 2025 | Monia Brett P | Director | A Award | 34,000 | Not measured | Not measured |
| Jun 18, 2025 | Kreis Leslie W. | Director | A Award | 34,000 | Not measured | Not measured |
| Jun 18, 2025 | Khattar Jack A. | Director | A Award | 34,000 | Not measured | Not measured |
| Jun 18, 2025 | Wallace Peggy | Director | A Award | 34,000 | Not measured | Not measured |
| Jun 18, 2025 | RICHSTONE ELLEN B | Director | A Award | 34,000 | Not measured | Not measured |
| Jun 18, 2025 | Fletcher Aaron G.L. | Director | A Award | 34,000 | Not measured | Not measured |
| May 1, 2025 | Doyle John Brendan | Chief Financial Officer | F Tax Payment | 9,692 | $0.4472 | $4,334 |
| Feb 15, 2025 | Doyle John Brendan | Chief Financial Officer | F Tax Payment | 1,723 | $0.5901 | $1,017 |
| Feb 15, 2025 | Caggiano Anthony | Chief Medical Officer | F Tax Payment | 5,296 | $0.5901 | $3,125 |
| Feb 15, 2025 | Ricciardi Lisa | CEO & President | F Tax Payment | 6,619 | $0.5901 | $3,906 |
| Feb 4, 2025 | Ricciardi Lisa | CEO & President | A Award | 631,300 | Not measured | Not measured |
| Feb 4, 2025 | Caggiano Anthony | Chief Medical Officer | A Award | 295,000 | Not measured | Not measured |
| Feb 4, 2025 | Doyle John Brendan | Chief Financial Officer | A Award | 295,000 | Not measured | Not measured |
| Feb 3, 2025 | Ricciardi Lisa | CEO & President | F Tax Payment | 28,960 | $0.6660 | $19,287 |
| Feb 3, 2025 | Caggiano Anthony | Chief Medical Officer | F Tax Payment | 12,779 | $0.6660 | $8,511 |
| Jan 31, 2025 | Ricciardi Lisa | CEO & President | P Purchase | 38,851 | $0.7722 | $30,001 |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.